RightSpotpH® ENFit Indicators

ENFit compatible gastric acidity verification for confirming NG/OG tube placement.

Used to validate placement of ENFit NG/OG tubes


Published studies cite that 21-56% of tubes intended for the stomach are confirmed elsewhere in the body.*

  • US Nursing and Patient Safety Organizations have issued warnings to stop using auscultation and recommend the use of pH to confirm gastric placement**
  • United Kingdom and most developed countries use pH first line to confirm NG/OG tube gastric placement and only use x-ray if pH is not conclusive.***
  • In 2018 the US ASPEN will endorse and publish a Clinical Practice Statement that says to use pH first line and only use x-ray if pH is not conclusive.

NPSA Patient Safety Alert (March 2011)***

Higher rates of misplacement with x-ray

Solution: RightSpotpH®

The ONLY FDA cleared, CE Marked, CLIA waived product that uses pH to confirm gastric acidity for tubes intended to end in the stomach.

  • Immediate results
  • No x-ray/radiation exposure
  • No daily QC requirements, no exposure to gastric fluids, accurate

Reimbursement: CPT Code 83986QW

Some think of using our pH indicators as an insurance policy to improve the safety of placing tubes with little to no added cost to the hospital. If your hospital is reimbursed for bedside glucose testing you may be able to get reimbursement for the RightSpotpH®

Single-use only. Latex free

*The Journal of Perinatal & Neonatal Nursing (2015) Following the Evidence. Enteral Tube Placement and Verification in Neonates and Young Children. Clifford, Patricia; Heimall, Lauren; Brittingham, Lori; Finn Davis, Katherine; Neonatal Intensive Care (2015) Validation Study of the RightSpot Infant pH Indicator for Verification of Feeding Tube Placement in the Neonatal Intensive Care Unit. Martin, Gregory C.; Wade, Christine.

**ENA Clinical Practice Guideline (2015); AACN Practice Alerts (2005 & 2016); CHABlind Pediatric NG Tube Placement Patient Safety Alert (2012)

***NPSA Patient Safety Alert, NHS (March 2011)

Join Industry Leaders

As more hospitals continually adopt ENFit technology to maximize patient safety, the RightSpotpH® indicator remains the most reliable choice for NG/OG tube placement confirmation. The RightSpotpH® indicator is ENFit compatible, and is increasingly becoming the international standard for confirming gastric tube placement. Below is a graphic showing ENFit conversion rates among top rated hospitals. With the combined reliability of ENFit connectors and RightSpotpH® indicators, healthcare professionals can achieve the true best practice for NG/OG tube placement.

ENFit is a registered trademark of GEDSA.

Frequently Asked Questions

The primary concern during NG or OG tube insertion is to ensure that the tube has not been inadvertently placed in the trachea, leading to the lungs. Such a misplacement could lead to severe complications, like pneumonia, if any fluids or medications are introduced. Misplacements can be detected immediately, allowing for quick corrective actions. This immediacy is crucial in critical care situations, where every second counts.

The indicator is sensitive to pH changes and is calibrated to detect the specific acidity levels of gastric aspirate. Once the aspirate is introduced to the indicator, it immediately reacts, displaying the pH level. In critical care scenarios, where time is of the essence, the swift response of the RightSpotpH® ENFit Indicator ensures that medical interventions aren't delayed by prolonged verification processes.

The RightSpotpH® ENFit Indicator allows healthcare providers to reduce the number of X-rays needed, leading to substantial cost savings and increased patient safety. Traditional methods, especially when secondary confirmations are necessary, can delay patient care, potentially leading to longer hospital stays and increased costs. It brings together enhanced patient safety, optimized healthcare processes, and tangible cost savings.

The RightSpotpH® ENFit Indicator, like many medical devices and indicators, is typically manufactured with the intent of single-use to guarantee the highest levels of precision and patient safety. Utilizing the device more than once might compromise its efficacy. Beyond just the concern for the device's accuracy, there's a critical concern about cross-contamination. Reusing any medical device that's meant for a one-time use can inadvertently introduce pathogens, potentially leading to infections.

Traditional methods of tube placement verification are not ideal. X-rays are time consuming and expensive, and auscultatory methods can be dangerously inaccurate. The RightSpotpH® ENFit Indicator provides almost instantaneous results, significantly reducing the time between tube insertion and confirmation of its proper placement. With the ability to confirm tube placement without the need for radiographic procedures, the RightSpotpH® ENFit Indicator reduces patient exposure to radiation. The ENFit design focuses on compatibility and ease of use, integrating seamlessly into current medical protocols and providing healthcare professionals with a tool that's both effective and user-friendly.

Typically, devices like the RightSpotpH® ENFit Indicator are designed for single-use, negating the need for cleaning or sterilization. Always consult the manufacturer's guidelines or the product manual for the most accurate and detailed information on storage, handling, and maintenance. These guidelines will provide comprehensive instructions tailored specifically for the RightSpotpH® ENFit Indicator. The RightSpotpH® ENFit Indicator is designed for ease and simplicity, ensuring proper storage and handling will maximize its effectiveness and maintain patient safety.

The RightSpotpH® ENFit Indicator is engineered with a universal design in mind. This ensures it can be seamlessly used with different types of tubes, whether they are inserted through the nose (NG) or mouth (OG). Using one device for both NG and OG tube verifications simplifies the process for healthcare professionals. They won't need to stock or differentiate between multiple tools, reducing potential confusion and streamlining procedures. Hospitals and medical facilities can benefit from the cost-efficiency of using a single tool for both NG and OG tube verifications. This eliminates the need to invest in separate devices or tools for each type of tube.

The indicator capitalizes on a basic physiological principle — gastric acidity. Gastric acid production is a consistent feature across different ages, from neonates to the elderly, making it a reliable metric for tube placement verification. One of the most significant benefits is the enhancement of patient safety irrespective of age. The ability to quickly and accurately determine tube placement can prevent severe complications like lung aspiration, which can be particularly detrimental in vulnerable age groups like neonates and the elderly.

Scroll to Top